© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#EASL 2011
Click Here for More Conferences
Click Here for EASL.eu
An Introduction to Hepatitis

Cholesterol Drug Statin May Improve Standard Hep C Treatment Efficacy

Medications sometimes prescribed to help manage high cholesterol levels also show promise as add-on treatments for hepatitis C

Boceprevir Effective in Advanced Fibrosis or Cirrhosis

Boceprevir can be used safely and effective in people living with hepatitis C virus (HCV) with advanced fibrosis or cirrhosis,

Pharmasset’s Two-Drug Non-Interferon Combo Packs Quick Hep C Punch

A combination of two experimental once-a-day drugs active against the hepatitis C virus (HCV) is showing excellent potential

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

New Interferon Boosts Efficacy, Reduces Side Effect Risk

An experimental version of pegylated interferon, Peg-Interferon lambda, combined with ribavirin (RBV) appears to be more effective with...

Breakthrough: Non-Interferon/Ribavirin Regimen Can Cure Hep C

A clinical trial suggests at least some cases of chronic HCV infection can be cured without use of either pegylated interferon or ribavirin.

Cyclophilin Inhibitor Alisporivir Shows Promise in Phase II Hep C Study

Alisporivir significantly improves sustained virologic response (SVR) rates when combined with standard pegylated interferon and ribavirin

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Once-Daily HCV Protease Inhibitor Meets Efficacy and Safety Goals in Phase II Studies

BI 201335 is one of several protease inhibitors being developed to treat HCV.

Telaprevir Improves Viral Cure Rates After Previous Treatment Failure

The only study completed to evaluate treatment on all major subgroups of people with genotype 1 HCV whose earlier treatment was unsuccessful
Advertisement
Science News
Newsfeed
Features
Ask Hep